NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Status COMPLETED Phase PHASE4
NCT00767975 Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison Status COMPLETED Phase PHASE3
NCT00760149 Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis Status COMPLETED Phase PHASE2
NCT00756808 Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes? Status COMPLETED Phase N/A
NCT00749034 Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects Status TERMINATED Phase PHASE1
NCT00741169 TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. Status COMPLETED Phase PHASE1
NCT00737724 Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment Status TERMINATED Phase NA
NCT00731471 A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV Status COMPLETED Phase PHASE1
NCT00728507 Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis Status TERMINATED Phase PHASE2
NCT00707967 Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults. Status COMPLETED Phase PHASE2
NCT00707317 T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals Status COMPLETED Phase N/A
NCT00698334 Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis Status COMPLETED Phase PHASE3
NCT00692809 Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection Status UNKNOWN Phase N/A
NCT00675961 Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia Status COMPLETED Phase NA
NCT00653770 A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A Status COMPLETED Phase PHASE1
NCT00653627 A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination Status COMPLETED Phase PHASE1